Skip to content

We are a multi-disciplinary team working on drug-resistant infections

People

Dr Catrin Moore

Professor in Global Health and Infectious Diseases

Dr Catrin Moore

Professor Catrin Moore

Professor in Global Health and Infectious Diseases

Catrin is the lead of this multi-disciplinary team, she is a microbiologist by training with nearly three-decades of experience in Global Health. She holds a DPhil in clinical medicine, an MBA, and an MSc in Medical Microbiology. She has a wide interest in microbiology having led clinical and research microbiology laboratories in Laos and Cambodia through the Oxford Tropical Network; clinical trials in West Africa while based in the Epidemic Diseases Research Group in Oxford; and large, complex public health data projects in partnership with the Global Burden of Disease group based at the Institute of Health Metrics and Evaluation.

Catrin is passionate about reducing the burden of drug-resistant infections and has a focus on surveillance: collecting the right, good quality data and evidence to inform interventions to minimise the burden of antibiotic resistance. She leads global and regional dialogues and multidisciplinary research in order to minimise AMR, with a focus on low- and middle-income countries.

Senior Research Project Manager

Becky Gathercole

Senior Research Project Manager

With over a decade of research management experience, Becky has worked across multiple specialties, including dementia, HIV/AIDS, and antimicrobial resistance. She completed an BSc in Psychology and Neuropsychology at the University of Bangor and holds an MSc in Clinical Trials from the London School of Hygiene and Tropical Medicine.

Project Manager

Dr Michiyo Iwami

Project Manager

Michiyo has a PhD in Health and Social Studies from the University of Warwick. She supports the team as Project Manager.

Honorary Clinical Lecturer

Dr Peter Crook

Honorary Clinical Lecturer

Dr Crook is an infectious diseases and internal medicine physician, with clinical experience in the UK and Rwanda. Alongside his clinical practice, he is involved in a range of medical education initiatives and is a Fellow of the Higher Education Academy. He is a mentor for the antimicrobial stewardship programme in Eswatini through the UK’s Fleming Fund.

Dr Crook is a Wellcome Trust PhD fellow through the Africa Health Research Training Programme (CREATE PhD), partnered with the Medical Research Council/Uganda Virus Research Institute (MRC-UVRI).

His research interests centre on antimicrobial resistance. He helped establish a multicentre cohort study for patients with drug-resistant tuberculosis in the UK (TB ShORRT UK). His PhD will build upon existing work into the impact of Gram-negative antimicrobial resistance in East Africa, focusing on the transmission dynamics of carbapenemase-producing Enterobacteriaceae in community settings.

He is committed to clinical research and education that inform evidence-based, patient-centred improvements in healthcare.

Senior Research Fellow

Dr Miriam Nantamu

Senior Research Fellow

Specialising in social science research, health professions education, and health systems research, Miriam has over a decade of experience across academia, healthcare, and research management. With a background in nursing, teaching, and doctoral research, Dr Nantamu has worked in both the UK and Uganda, contributing to global health and international development initiatives. Her work is grounded in rigorous qualitative and mixed-methods research, with a strong commitment to improving health systems and professional practice.

Postdoctoral Bioinformatician

Dr Arun Decano

Postdoctoral Bioinformatician

Arun holds an MSc in Medical Microbiology and a PhD in Genetics, specialising in pathogen genomics, genome sequencing and phylodynamics. Her work focuses on antimicrobial resistance and genomic surveillance, with expertise in reproducible workflow development, short and long-read sequencing applications, and comparative genomics across clinical and One Health settings.

Research Fellow

Dr Juliet Namugambe

Research Fellow

Dr Juliet Sanyu Namugambe has over 13 years of experience in health systems strengthening across low- and middle-income countries (LMICs). Her work focuses on policy development, advocacy, and programme implementation at national and regional levels. She has particular expertise in antimicrobial resistance and stewardship, medicine quality, and is committed to advancing evidence-based practice through research and academia.

Dr Namugambe holds a PhD in Tropical and Infectious Diseases from the London School of Hygiene & Tropical Medicine, a Master’s in Clinical Pharmacy from University College London, and a Bachelor’s degree in Pharmacy from Makerere University, Uganda.

Research Fellow

Setah Alavi

Research Fellow

Setah focuses on community-based antibiotic use and resistance through the CAST-UTI project. She leads data management and analysis for CAST, working with large antibiotic datasets to understand treatment pathways and resistance patterns outside hospital settings, and has contributed to the CURE project through the systematic review.  She holds an MSc in Clinical and Public Health Nutrition from University College London and a BSPH from Tulane University.

PhD Student

Millie Williams-Walker

PhD Student

Millie is a second year PhD student on the MRC-LID doctoral studentship programme with a primary research focus on the antimicrobial resistance of community-acquired urinary tract infections. Prior to starting her PhD she completed an undergraduate degree in Biological Sciences at the University of Exeter and an MPhil in Molecular Immunology and Infection Biology at the University of Cambridge.

PhD Student

Max Wallat

PhD Student

Max is a PhD student on the MRC LID studying antimicrobial resistance in Methicillin Resistant Staphylococcus aureus (MRSA), combine experimental evolution in the lab with Whole Genome Sequencing (WGS) data analysis to uncover determinants of horizontal gene transfer in clinical isolates of MRSA. He is supervised by Professor Jodi Lindsay (RVC), Professor Gwen Knight, and Kat Holt (both LSHTM), as well as Catrin & colleagues at CSG (Tooting Campus). He is passionate about science communication, teaching, and community building.

USA

BioAmp

USA

BioAmp Diagnostics is a US-based diagnostics company developing rapid precision tools to direct antibiotic prescribing for infections, including complicated UTIs. Their proprietary DETECT technology delivers results in minutes rather than days, enabling evidence-based treatment decisions and supporting judicious antibiotic use.

Uganda

Infectious Diseases Research Collaboration

Uganda

Dr James Kapisi and the team and IDRC are supporting recruitment to the CAST-UTI project.

Uganda

Makarere University

Uganda

Led by Prof Henry Kajumbula, the team at Makarere University are supporting recruitment to the CAST-UTI project and providing diagnostic testing on the samples collected from participants.

France

SmartBiotic

France

SmartBiotic is an AI-powered antimicrobial stewardship tool that analyses a hospital’s local bacteriological data to generate tailored, patient-specific antibiotic prescribing recommendations. smartbiotic By making under-utilised laboratory data actionable at the point of care, SmartBiotic supports clinicians in selecting the right antibiotic for the right patient, helping to reduce antimicrobial overuse and combat AMR.

UK

Royal Veterinary College

UK

RVC have partnered with us on the Fleming Fund Fellowship where they provide mentors for a number of the fellows.

Hong Kong

University of Hong Kong

Hong Kong

Prof Celine Chui is using big data to investigate the disease risk and risk factor of AMR in Hong Kong, To study the incidence trend for Carbapenem-Resistant Enteriaceae in Hong Kong

UK

University of Leeds

UK

Dr Anne-Sophie Jung (Lecturer in Global Health) collaborated on focuses groups that formed part of the work of the CURE project.

UK

University of Manchester

UK

Sweden

UTI-lizer

Sweden

Utilizer is a Swedish medtech company developing an innovative point-of-care UTI testing system that combines bacterial culture-level accuracy with digital readout via smartphone. Designed for use in primary care settings, Utilizer-ID aims to reduce misdiagnosis, cut unnecessary antibiotic prescribing, and improve outcomes for the hundreds of millions of patients affected by UTIs each year.

We are working on a number of projects. Most of these are focused on drug-resistant infections specifically relating to UTIs. These include:

Browse projects

ADILA

Antibiotic Data to Inform Local Action

The project aimed to develop open-access analyses and tools to guide national and local antibiotic prescribing policies. Key objectives included developing a methodology for deriving AWaRe-based national antibiotic targets, AWaRe quality indicators, methodology for collecting antibiotic prescribing data in primary healthcare, and for estimating expected antibiotic use in hospital and primary care based on clinical burden.

Partners: University of Antwerp, University of Oxford, Liverpool School of Tropical Medicine, Mahidol Oxford Tropical Research Unit,
Cambodia Oxford Medical Research Unit, National University of Singapore, Kenya Medical Research Institute

Researchers: Profs Michael Sharland and Catrin Moore at City St George’s, University of London, Dr Koen Pouwels at Nuffield Department of Primary Care Health Science and Dr Ben Cooper at Centre for Tropical Medicine and Global Health at the University of Oxford

Funders: The Wellcome Trust

Website: Antibiotic Policy Group – ADILA

CAST-UTI

Comparison of community and hospital Antibiotic use practices, Susceptibility and resisTance and determinants of care seeking among patients with Urinary Tract Infections.

This pilot study examines antibiotic resistance in acute urinary tract infections across two socioeconomically diverse Kampala neighbourhoods. The research investigates patients who visit community pharmacies and outpatient clinics, comparing local resistance patterns with WHO Uganda data whilst examining prescribing practices, patient demographics and multi-drug resistance prevalence.

Using phenotypic and genomic techniques, together with social science to understand the patient pathways for treatment. The study aims to establish a framework applicable to other low- and middle-income countries, facilitating intervention strategies to promote appropriate antibiotic use and reduce antimicrobial resistance-related mortality.

Partners: Makerere University, Infectious Disease Research Centre, BioAmp, UTI-lizer
Researchers: To be added
Funder: The Wellcome Trust

Outputs

Lorem ipsum dolor sit amet consectetur. Aliquet sodales quis in purus aliquam eget. Elementum eget ultrices et volutpat ut. Sem leo tristique justo tortor. Mattis in volutpat cras neque molestie pharetra proin. Sed elementum congue ipsum mus felis leo vitae. Enim id luctus in in ridiculus vitae. Iaculis vestibulum nulla amet nulla. Faucibus purus eget cras enim nunc facilisi sollicitudin diam. Nunc elementum pellentesque nunc sed fringilla arcu ut.

CURE

The Comprehensive Understanding of Disease and AI Research project

The CURE project addresses antimicrobial resistance by creating a comprehensive global data landscape mapping clinical, microbiological and antimicrobial use information. Using novel artificial intelligence tools, the project will describe the data landscape and begin to harmonise disparate datasets by outlining a common data platform that could be used. With SmartBiotic the team are harmonising data, using AI algorithms to enhance and fill gaps in currently existing clinical microbiology data which is informing evidence-based treatment guidelines. Through systematic reviews and collaboration with international experts, CURE will develop freely available tools that establish a scalable platform for AMR data, with future expansion planned across the One Health framework to support global efforts in reducing inappropriate antibiotic prescribing.

Partners: SmartBiotic, University of Leeds

Researchers: Dr Anne-Sophie Jung, Prof Ed Alonso, Dr Fredrick Mutisya, Louis Vezard, Taïoh Yokoyama, Dr Sana Boujaafar, Dr Mathieu Raad, Prof Catrin Moore

Funder: iiCON & UKRI

Knocking out AMR

Prof Moore co-leads the Microbiology Society’s Knocking Out AMR project, a four-year initiative addressing the global antimicrobial resistance crisis. The project has convened 135 experts across One Health sectors to develop solutions in surveillance, diagnostics, vaccines and policy. Prof Moore led workshops in 2025 using an innovative complex systems approach. The initiative identified barriers and interventions, with findings published online. Prof Moore leads engagement activities including the AMR in Focus series, educational resources and collaboration with UK health agencies, representing the Society at high-level policy meetings including the 2024 UN General Assembly on AMR.

Website: Knocking Out Antimicrobial Resistance | Microbiology Society

The Fleming Fund Fellowship in Eswatini

This Fellowship Scheme strengthens antimicrobial resistance workforce capacity by supporting professional development of practitioners within government institutions across Fleming Fund countries. Our team of mentors in CSG and RVS mentor fellows in specialised disciplines, they are in turn training their colleagues using their newly acquired skills. The programme focuses on advanced scientific and leadership development, bringing together human, animal health and environment professionals through a One Health approach. The team are currently supporting nine fellows in Eswatini, the scheme enhances capabilities in AMR diagnostic data collection, surveillance, data management and practical application to improve national AMR response. Two of the current Fellows recently ran a workshop on microbiology quality improvement in Piggs Peak, Eswatini which was supported by this work and the British High Commission in Eswatini.

Partners: Royal Veterinary College, University of London

Beneficiary Institutions: Eswatini Ministry of Health, Department of Veterinary Services – Central Veterinary Laboratory, Hlathikhulu Government Hospital, Good Shepherd Mission Hospital, Department of Water Affairs, Ministry of Agriculture Veterinary Public Health Division Food Hygiene Laboratory, Mbabane Government Hospital Laboratory

Mentors: Prof Catrin Moore, Prof Jodi Lindsay, Dr Yingfen Hsia, Dr Kurt Arden, Dr Sian Frosini, Dr Steven van Winden, Prof Anette Loeffler, Prof Tariq Sadiq, Dr Peter Crook, Dr Lauren Hookham, Dr Richard Booth, Dr Sally Baker

Mentees:
Andiswa Tenkhosi Dlamini – AMR Laboratory – Human Health
Bongiwe Elizabeth Ngozo – AMU-C Surveillance – Animal Health
Makhosazana Shongwe (Khosi) – AMR Laboratory – Environment
Precious Mumbi Chishimba – AMU-C Surveillance – Human Health
Nelisiwe Euphene Khumalo – AMU-C Surveillance – Animal Health
Melusi Welcome Mthembu – Antimicrobial Stewardship – Human Health
Nomcebo Fortunate Zondo – Antimicrobial Stewardship – Human Health
Bavukile Siphosethu Kunene – Antimicrobial Stewardship – Animal Health
Sifundo Patience Zwane – AMR Policy – Human Health

Alumni:
Mcolisi Buyisizwe Fakudze – AMR Laboratory – Animal Health
Zizwe M. Cindzi – AMU/C – Animal Health
Ronnie Mkoko – AMR Surveillance – Human Health
Sihle Gamma – AMU/C – Human Health

Funder: Department of Health & Social Care

Website: Fleming Fund Fellowships

The Fleming Fund Technical Assistance for Clinical Engagement Africa & Asia

Building on the ADILA initiative, the teams role in TACE is to enhance antimicrobial use data and quality across low- and middle-income countries in Africa and Asia. In partnership with IVI (Asia lead) and Fondation Mérieux (African lead), the project strengthens local surveillance and stewardship through training, technical support and through the use of data analysis tools. The TACE project promotes appropriate antibiotic prescribing using AWaRe Quality Indicators and a visualisation dashboard, enabling healthcare teams to integrate data into clinical care. The project empowers countries to address antimicrobial resistance through targeted, context-specific strategies based on local evidence.

Partners: University of Oxford, Global Point Prevalence Survey, International Vaccine Institute, Fondation Mérieux

Funder: Department of Health & Social Care

Websites: TACE AFRICA | TACE ASIA

Glossary

ADILA (Antibiotic Data to Inform Local Action)

A previous initiative focused on antimicrobial use surveillance that informed the development of the TACE project

AMR (Antimicrobial Resistance)

When bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder to treat

AMU (Antimicrobial Use)

The consumption and prescribing patterns of antimicrobial medicines, including antibiotics

AWaRe

Quality Indicators
Assessment tools developed under ADILA to evaluate antibiotic prescribing practices. AWaRe classifies antibiotics as Access, Watch or Reserve based on their importance

CDRO (Community Drug Retail Outlet)

Pharmacies and drug shops in community settings where patients can obtain medicines

CURE (Comprehensive Understanding of Disease and AI Research)

A project using artificial intelligence to harmonise global antimicrobial resistance data

Fleming Fund

An international programme supporting low- and middle-income countries to strengthen antimicrobial resistance surveillance

Fondation Mérieux

An organisation leading consortium work on antimicrobial use in Africa

Genotypic/Genomic techniques

Laboratory methods that analyse the genetic material of bacteria to identify resistance genes

IVI (International Vaccine Institute)

An organisation leading consortium work on antimicrobial use in Asia

LMIC (Low- and Middle-Income Country)

Countries with lower economic development, often facing greater challenges in healthcare infrastructure

Multidrug resistance

When bacteria are resistant to multiple different antibiotics

One Health

An approach recognising that human, animal and environmental health are interconnected

OPD (Outpatient Clinic/Department)

Healthcare facilities where patients receive treatment without being admitted to hospital

Phenotypic techniques

Laboratory methods that test how bacteria respond to antibiotics in practice

Point Prevalence Survey (PPS)

A snapshot assessment of antibiotic use and prescribing practices at a specific point in time

Stewardship

Coordinated programmes to improve appropriate use of antimicrobials, including prescribing practices and treatment guidelines

TACE (Technical Assistance for Clinician Engagement)

A project enhancing antimicrobial use data quality and stewardship in Africa and Asia

UTI (Urinary Tract Infection)

An infection in any part of the urinary system, commonly treated with antibiotics

WHO-GLASS (World Health Organization Global Antimicrobial Resistance and Use Surveillance System)

WHO’s global system for collecting and analysing antimicrobial resistance data to inform policy